论文信息 - 2023 ESC Guidelines for the management of acute coronary syndromes.

2023 ESC Guidelines for the management of acute coronary syndromes.

[1] P. Damman,et al. Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial , 2023, European heart journal.

[2] X. Rosselló,et al. Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines , 2023, European heart journal. Quality of care & clinical outcomes.

[3] Min Chul Kim,et al. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. , 2022, European heart journal.

[4] J. Karásek,et al. Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial , 2022, Circulation.

[5] C. Hassager,et al. Duration of Device-Based Fever Prevention after Cardiac Arrest. , 2022, The New England journal of medicine.

[6] Y. Liu,et al. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial , 2022, The Lancet.

[7] A. von Eckardstein,et al. Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm. , 2022, American heart journal.

[8] H. Schunkert,et al. Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial , 2022, Circulation.

[9] G. Levine,et al. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association , 2022, Circulation.

[10] A. Greco,et al. How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology (EAPC). , 2022, European journal of preventive cardiology.

[11] C. Eek,et al. Guideline‐Recommended Time Less Than 90 Minutes From ECG to Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction Is Associated with Major Survival Benefits, Especially in Octogenarians: A Contemporary Report in 11 226 Patients from NORIC , 2022, Journal of the American Heart Association.

[12] R. Holman,et al. Empagliflozin in acute myocardial infarction: the EMMY trial , 2022, European heart journal.

[13] Jose H. Flores-Arredondo,et al. Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease , 2022, Circulation.

[14] Akshay S. Desai,et al. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. , 2022, The New England journal of medicine.

[15] G. Boriani,et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal.

[16] F. Van de Werf,et al. Polypill Strategy in Secondary Cardiovascular Prevention. , 2022, The New England journal of medicine.

[17] L. Räber,et al. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation , 2022, The Lancet.

[18] A. Arizá-Solé,et al. Coronariografía urgente en los pacientes con parada cardiaca extrahospitalaria sin elevación del segmento ST , 2022, Revista Española de Cardiología.

[19] L. Tavazzi,et al. EURObservational Research Programme: a bibliometric assessment of its scientific output. , 2022, European heart journal. Quality of care & clinical outcomes.

[20] N. Desai,et al. Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2022, JAMA internal medicine.

[21] V. Kunadian,et al. Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients undergoing invasive care , 2022, BMJ Open.

[22] G. Chatellier,et al. Emergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac Arrest: Results of the Randomized, Multicentric EMERGE Trial. , 2022, JAMA cardiology.

[23] J. M. Fernández,et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial , 2022, The Lancet.

[24] Deepak L. Bhatt,et al. Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial. , 2022, American heart journal.

[25] A. Attar,et al. Effect of Treatment with Colchicine after Acute Coronary Syndrome on Major Cardiovascular Events: A Systematic Review and Meta-Analysis of Clinical Trials , 2022, Cardiovascular therapeutics.

[26] L. Räber,et al. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. , 2022, JAMA.

[27] B. Lindahl,et al. Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[28] K. Tanabe,et al. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial. , 2022, JAMA cardiology.

[29] G. Mintz,et al. EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency. , 2022, JACC. Cardiovascular interventions.

[30] Hong Wang,et al. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. , 2022, JACC. Cardiovascular imaging.

[31] Yuquan He,et al. Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction. , 2022, JACC. Cardiovascular interventions.

[32] W. Luo,et al. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta‐analysis of randomized controlled trials , 2022, Clinical Rheumatology.

[33] E. Vicaut,et al. One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial. , 2022, Circulation.

[34] R. Mehran,et al. Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes. , 2022, JACC. Cardiovascular interventions.

[35] aguda y crónica,et al. Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2022, Revista espanola de cardiologia.

[36] J. Soar,et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults. , 2022, Resuscitation.

[37] S. Petersen,et al. European Society of Cardiology: cardiovascular disease statistics 2021. , 2022, European heart journal.

[38] M. Pombo,et al. Comments on the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. , 2022, Revista espanola de cardiologia.

[39] M. Trivella,et al. Transfusion thresholds for guiding red blood cell transfusion. , 2021, The Cochrane database of systematic reviews.

[40] G. Perkins,et al. Impact of Cardiac Arrest Centers on the Survival of Patients With Nontraumatic Out‐of‐Hospital Cardiac Arrest: A Systematic Review and Meta‐Analysis , 2021, Journal of the American Heart Association.

[41] V. Kunadian,et al. Is the contemporary care of the older persons with acute coronary syndrome evidence-based? , 2021, European heart journal open.

[42] M. Togni,et al. Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions , 2021, Frontiers in Cardiovascular Medicine.

[43] S. Solomon,et al. Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction , 2021, New England Journal of Medicine.

[44] M. Sabatine,et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis , 2021, The Lancet.

[45] D. Stub,et al. Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes , 2021, JAMA network open.

[46] Min Chul Kim,et al. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial , 2021, The Lancet.

[47] E. V. van Beek,et al. Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction , 2021, Journal of the American College of Cardiology.

[48] S. Lewis,et al. Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial , 2021, BMJ.

[49] L. Køber,et al. Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial , 2021, Journal of the American Heart Association.

[50] D. Morrow,et al. Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams. , 2021, Journal of the American College of Cardiology.

[51] J. Ferrières,et al. Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI. , 2021, Journal of the American College of Cardiology.

[52] J. Saw,et al. Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial. , 2021, Revista espanola de cardiologia.

[53] M. Neuhäuser,et al. Coronary Artery Bypass Graft Surgery in Patients With Acute Coronary Syndromes After Primary Percutaneous Coronary Intervention: A Current Report From the North‐Rhine Westphalia Surgical Myocardial Infarction Registry , 2021, Journal of the American Heart Association.

[54] A. von Eckardstein,et al. Performance of the ESC 0/2h-Algorithm using High-Sensitivity Cardiac Troponin I in the Early Diagnosis of Myocardial Infarction. , 2021, American heart journal.

[55] J. Tijssen,et al. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome. , 2021, Journal of the American College of Cardiology.

[56] I. V. Van Gelder,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[57] Ò. Miró,et al. Prospective Validation of the ESC 0/1h-Algorithm Using High-Sensitivity Cardiac Troponin I. , 2021, The American journal of cardiology.

[58] A. Íñiguez,et al. Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting , 2021, Circulation.

[59] M. Gold,et al. European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[60] G. Filippatos,et al. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction , 2021, Circulation.

[61] I. König,et al. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. , 2021, The New England journal of medicine.

[62] A. Íñiguez,et al. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. , 2021, The New England journal of medicine.

[63] G. Boriani,et al. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. , 2021, European heart journal. Acute cardiovascular care.

[64] P. Ponikowski,et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. , 2021, The New England journal of medicine.

[65] S. E. Jensen,et al. Influenza Vaccination After Myocardial Infarction , 2021, Circulation.

[66] R. Mehran,et al. Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives. , 2021, Journal of the American College of Cardiology.

[67] Ò. Miró,et al. Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm , 2021, Circulation.

[68] B. Ibáñez,et al. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). , 2021, European heart journal. Cardiovascular pharmacotherapy.

[69] L. Wallentin,et al. Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) , 2021, European heart journal. Quality of care & clinical outcomes.

[70] A. Baranchuk,et al. Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation , 2021, Global heart.

[71] C. Gale,et al. Safety of Early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[72] I. Porto,et al. Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry. , 2021, European heart journal.

[73] Stuart J. Pocock,et al. Las diferencias por sexo en la mortalidad tras un síndrome coronario agudo se incrementan en los países de menor riqueza y mayor desigualdad de ingresos , 2021, Revista Española de Cardiología.

[74] D. Stub,et al. Cost-effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome. , 2021, The American journal of cardiology.

[75] G. De Backer,et al. Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys. , 2021, European journal of preventive cardiology.

[76] S. Kohsaka,et al. De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes. , 2021, Journal of the American College of Cardiology.

[77] H. Schunkert,et al. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial. , 2021, JAMA cardiology.

[78] D. Capodanno,et al. Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA). , 2021, European heart journal. Acute cardiovascular care.

[79] N. Desai,et al. Outcomes of mechanical circulatory support for acute myocardial infarction complicated by cardiogenic shock , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[80] X. Rosselló,et al. Assessment of the ESC quality indicators in patients with acute myocardial infarction: a systematic review. , 2021, European heart journal. Acute cardiovascular care.

[81] C. Callaway,et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest , 2021, New England Journal of Medicine.

[82] P. Serruys,et al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials , 2021, BMJ.

[83] Mauricio G. Cohen,et al. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association , 2021, Circulation.

[84] M. Piepoli,et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. , 2021, European journal of preventive cardiology.

[85] S. Halvorsen,et al. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway , 2021, European heart journal. Cardiovascular pharmacotherapy.

[86] J. Maessen,et al. Mechanical Circulatory Support as a Bridge to Definitive Treatment in Post-Infarction Ventricular Septal Rupture. , 2021, JACC. Cardiovascular interventions.

[87] F. Apple,et al. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay , 2021, Clinical chemistry and laboratory medicine.

[88] G. Chatellier,et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. , 2021, The New England journal of medicine.

[89] James R. Campbell,et al. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. , 2021, The New England journal of medicine.

[90] Deepak L. Bhatt,et al. Impact of Chronic Kidney Disease on Revascularization and Outcomes in Patients with ST-Elevation Myocardial Infarction. , 2021, The American journal of cardiology.

[91] G. MacGowan,et al. Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome , 2021, Heart.

[92] M. Jeong,et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial , 2021, The Lancet.

[93] C. Cannon,et al. Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome , 2021, Clinical Research in Cardiology.

[94] H. Thiele,et al. Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial , 2021, Journal of the American Heart Association.

[95] F. Giallauria,et al. Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art , 2021, Journal of clinical medicine.

[96] J. Soar,et al. European Resuscitation Council Guidelines 2021: Executive summary. , 2021, Resuscitation.

[97] V. Kunadian,et al. Frailty Scores and Their Utility in Older Patients with Cardiovascular Disease , 2021, Interventional cardiology.

[98] M. Morsi,et al. Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi (No-LVT Trial). , 2021, Journal of the American College of Cardiology.

[99] J. Soar,et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care , 2021, Intensive Care Medicine.

[100] Richard A. Parker,et al. High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction , 2021, Circulation.

[101] M. Gulati,et al. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis , 2021, Journal of the American Heart Association.

[102] P. Serruys,et al. 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction. , 2021, Journal of the American College of Cardiology.

[103] Ò. Miró,et al. Diagnostic Performance of the European Society of Cardiology 0/1-h Algorithms in Late Presenters. , 2021, Journal of the American College of Cardiology.

[104] H. White,et al. High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial , 2021, BMJ.

[105] H. Elming,et al. Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. , 2021, Journal of the American College of Cardiology.

[106] E. Navarese,et al. ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial , 2021, BMJ Open.

[107] P. Kirchhof,et al. Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock , 2021, ESC heart failure.

[108] E. Vicaut,et al. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. , 2021, JAMA.

[109] Deepak L. Bhatt,et al. Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis. , 2021, European heart journal. Acute cardiovascular care.

[110] Youssef S. Abdelwahed,et al. Feasibility and diagnostic reliability of quantitative flow ratio in the assessment of non-culprit lesions in acute coronary syndrome , 2021, The International Journal of Cardiovascular Imaging.

[111] H. Bueno,et al. The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries. , 2021, European heart journal. Acute cardiovascular care.

[112] H. Thiele,et al. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group. , 2021, European heart journal. Acute cardiovascular care.

[113] F. D’Ascenzo,et al. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets , 2021, The Lancet.

[114] E. Hagström,et al. Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study , 2020, European heart journal.

[115] A. Roguin,et al. Direct Admission of Patients With ST‐Segment–Elevation Myocardial Infarction to the Catheterization Laboratory Shortens Pain‐to‐Balloon and Door‐to‐Balloon Time Intervals but Only the Pain‐to‐Balloon Interval Impacts Short‐ and Long‐Term Mortality , 2020, Journal of the American Heart Association.

[116] K. Maganti,et al. Mechanical Complications of Acute Myocardial Infarction: A Review. , 2020, JAMA cardiology.

[117] R. Mehran,et al. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials. , 2020, European heart journal.

[118] Ying Zhang,et al. Effects of morphine on P2Y12 platelet inhibitors in patients with acute myocardial infarction: A meta-analysis. , 2020, The American journal of emergency medicine.

[119] J. Saw,et al. Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of MINOCA in Women. , 2020, Circulation.

[120] S. Ranka,et al. Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis , 2020, Thrombosis Journal.

[121] Deepak L. Bhatt,et al. Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. , 2020, JAMA cardiology.

[122] P. Fitzgerald,et al. Invasive Assessment of Myocardial Bridging in Patients with Angina and No Obstructive Coronary Artery Disease. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[123] V. Fuster,et al. Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation , 2020, European heart journal.

[124] E. Omerovic,et al. Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes , 2020, JAMA network open.

[125] Samin K. Sharma,et al. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. , 2020, European heart journal.

[126] M. Krempf,et al. Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction , 2020, European heart journal. Acute cardiovascular care.

[127] J. McMurray,et al. Dapagliflozin in Patients with Chronic Kidney Disease. , 2020, The New England journal of medicine.

[128] B. Lindahl,et al. Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry , 2020, Scientific Reports.

[129] Jun-Jie Zhang,et al. 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. , 2020, JACC. Cardiovascular interventions.

[130] Chiu-Hsieh Hsu,et al. Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation , 2020, Circulation.

[131] H. Crijns,et al. Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. , 2020, JAMA cardiology.

[132] B. Lindahl,et al. Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome , 2020, Circulation.

[133] G. Hankey,et al. Colchicine in Patients with Chronic Coronary Disease. , 2020, The New England journal of medicine.

[134] I. V. Van Gelder,et al. Quality indicators for the care and outcomes of adults with atrial fibrillation. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[135] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[136] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[137] P. Ponikowski,et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure , 2020, New England Journal of Medicine.

[138] J. Bae,et al. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial , 2020, The Lancet.

[139] I. Ekman,et al. A systematic review on implementation of person-centered care interventions for older people in out-of-hospital settings. , 2020, Geriatric nursing.

[140] A. Klein,et al. Pericarditis and Post-cardiac Injury Syndrome as a Sequelae of Acute Myocardial Infarction , 2020, Current Cardiology Reports.

[141] G. Musumeci,et al. Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome. , 2020, Journal of the American College of Cardiology.

[142] C. Baigent,et al. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. , 2020, European heart journal. Quality of care & clinical outcomes.

[143] S. Schlesinger,et al. Dose–response relationship between physical activity and mortality in adults with noncommunicable diseases: a systematic review and meta-analysis of prospective observational studies , 2020, International Journal of Behavioral Nutrition and Physical Activity.

[144] S. Hayes,et al. Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.

[145] Deepak L. Bhatt,et al. Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis , 2020, Journal of the American Heart Association.

[146] F. Crea,et al. Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease , 2020, JACC. Cardiovascular interventions.

[147] C. Beghi,et al. The use of extracorporeal membrane oxygenation in the setting of postinfarction mechanical complications: outcome analysis of the Extracorporeal Life Support Organization Registry. , 2020, Interactive cardiovascular and thoracic surgery.

[148] Christopher W. Jones,et al. Using Sex‐specific Cutoffs for High‐sensitivity Cardiac Troponin T to Diagnose Acute Myocardial Infarction , 2020, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[149] M. Cowie,et al. SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control , 2020, Nature Reviews Cardiology.

[150] A. Baumbach,et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. , 2020, European heart journal.

[151] Dominique Hansen,et al. The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology , 2020, European journal of preventive cardiology.

[152] J. Singer,et al. High-Sensitivity Cardiac Troponin-Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women (CODE-MI): Rationale and design for a multicenter, stepped-wedge, cluster-randomized trial. , 2020, American heart journal.

[153] G. Corrao,et al. Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes: Evidence from an Italian real-world investigation. , 2020, International journal of cardiology.

[154] D. Panagiotakos,et al. Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC). , 2020, European journal of preventive cardiology.

[155] Y. Jang,et al. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial. , 2020, JAMA.

[156] E. Guallar,et al. Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study. , 2020, European heart journal.

[157] R. Yeh,et al. Comparison of Reperfusion Strategies for ST‐Segment–Elevation Myocardial Infarction: A Multivariate Network Meta‐analysis , 2020, Journal of the American Heart Association.

[158] P. Doherty,et al. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiolog , 2020, European journal of preventive cardiology.

[159] G. Filippatos,et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.

[160] S. E. Jensen,et al. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial , 2020, Trials.

[161] Ò. Miró,et al. Early kinetics of cardiac troponin in suspected acute myocardial infarction. , 2020, Revista espanola de cardiologia.

[162] D. Wood,et al. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. , 2020, JAMA cardiology.

[163] B. Lewis,et al. Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial. , 2020, JAMA cardiology.

[164] M. Sebbane,et al. Nitrous oxide/oxygen plus acetaminophen versus morphine in ST elevation myocardial infarction: open-label, cluster-randomized, non-inferiority study , 2020, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

[165] F. Rutten,et al. Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta‐analysis , 2020, Journal of the American Heart Association.

[166] T. Gleason,et al. Mitral Valve Surgery for Papillary Muscle Rupture: Outcomes in 1,342 Patients from the STS Database. , 2020, The Annals of thoracic surgery.

[167] G. Condorelli,et al. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis , 2020, The Lancet.

[168] I. Hegazi,et al. Understanding Patient Expectations of Health Care: A Qualitative Study , 2020, Journal of patient experience.

[169] Lang Li,et al. Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis , 2020, BMC Pharmacology and Toxicology.

[170] M. Voskuil,et al. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial , 2020, The Lancet.

[171] H. Thiele,et al. Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Ticagrelor-Induced Platelet Inhibition in Acute Myocardial Infarction: The Randomized MonAMI Trial. , 2020, Circulation.

[172] D. Rahelić,et al. Mediterranean diet, cardiovascular disease and mortality in diabetes: A systematic review and meta-analysis of prospective cohort studies and randomized clinical trials , 2020, Critical reviews in food science and nutrition.

[173] W. Gi,et al. Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis , 2020, Heart.

[174] S. Chaudhry,et al. Patient and Cardiologist Perspectives on Shared Decision Making in the Treatment of Older Adults Hospitalized for Acute Myocardial Infarction , 2020, Medical decision making : an international journal of the Society for Medical Decision Making.

[175] Dominique Hansen,et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. , 2020, European journal of preventive cardiology.

[176] C. Granger,et al. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention , 2020, Circulation.

[177] J. Herrmann. Vascular toxic effects of cancer therapies , 2020, Nature Reviews Cardiology.

[178] J. Goldman,et al. Transition of care to prevent recurrence after acute coronary syndrome: the critical role of the primary care provider and pharmacist , 2020, Postgraduate medicine.

[179] S. Pocock,et al. Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking , 2020, European heart journal. Acute cardiovascular care.

[180] S. James,et al. Patient experience of the informed consent process during acute myocardial infarction: a sub-study of the VALIDATE-SWEDEHEART trial , 2020, Trials.

[181] R. Gallagher,et al. Health-related quality of life and exercise-based cardiac rehabilitation in contemporary acute coronary syndrome patients: a systematic review and meta-analysis , 2020, Quality of Life Research.

[182] Deepak L. Bhatt,et al. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. , 2020, JAMA cardiology.

[183] P. Doherty,et al. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II) , 2020, European journal of preventive cardiology.

[184] G. De Backer,et al. Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V , 2020, Diabetes Care.

[185] C. von Birgelen,et al. Involving the patient's perspective and preferences concerning coronary angiography and percutaneous coronary intervention. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[186] D. Pinto,et al. Intravascular Ultrasound Imaging–Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis , 2020, Journal of the American Heart Association.

[187] A. Messerli,et al. Implementation of institutional discharge protocols and transition of care following acute coronary syndrome. , 2020, Cardiovascular revascularization medicine : including molecular interventions.

[188] H. Elming,et al. Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. , 2020, Journal of the American College of Cardiology.

[189] D. Wald,et al. Should Fractional Flow Reserve follow Angiographic Visual Inspection to guide Preventive PCI in STEMI? , 2020, European heart journal. Quality of care & clinical outcomes.

[190] J. Messenger,et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2020, JAMA.

[191] A. Colombo,et al. Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? , 2020, European heart journal. Quality of care & clinical outcomes.

[192] Deepak L. Bhatt,et al. Meta‐analysis of optimal timing of coronary intervention in non‐ST‐elevation acute coronary syndrome , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[193] A. Jackson,et al. Anxiety and Depression After a Cardiac Event: Prevalence and Predictors , 2020, Frontiers in Psychology.

[194] R. Giugliano,et al. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography. , 2020, Journal of the American College of Cardiology.

[195] D. Fine,et al. Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease , 2020, Kidney medicine.

[196] A. Jacobs,et al. Prehospital Activation of Hospital Resources (PreAct) ST‐Segment–Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline Program , 2020, Journal of the American Heart Association.

[197] D. Safran,et al. Re: Health Care Spending, Utilization, and Quality 8 Years into Global Payment. , 2020, The Journal of urology.

[198] Meron Hirpa,et al. What matters to patients? A timely question for value-based care , 2020, bioRxiv.

[199] T. Omland,et al. Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; Data from the Akershus Cardiac Examination (ACE) 3 Study. , 2019, Clinical biochemistry.

[200] H. Suryapranata,et al. Final results of the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation stent (REDUCE) trial. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[201] D. Fischman,et al. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. , 2019, European heart journal.

[202] D. Xavier,et al. Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial. , 2019, Circulation.

[203] L. Vanhees,et al. Home-based exercise with telemonitoring guidance in patients with coronary artery disease: Does it improve long-term physical fitness? , 2019, European journal of preventive cardiology.

[204] N. Samani,et al. Spontaneous Coronary Artery Dissection: Pathophysiological Insights From Optical Coherence Tomography. , 2019, JACC. Cardiovascular imaging.

[205] F. Astin,et al. Cardiologists’ and patients’ views about the informed consent process and their understanding of the anticipated treatment benefits of coronary angioplasty: A survey study , 2019, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[206] L. Räber,et al. Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS). , 2019, Journal of the American College of Cardiology.

[207] J. Spertus,et al. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support , 2019, Circulation.

[208] R. Diaz,et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.

[209] N. Lakkis,et al. Meta-analysis Comparing Multivessel Versus Culprit Coronary Arterial Revascularization for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. , 2019, American Journal of Cardiology.

[210] C. Granger,et al. Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial. , 2019, Circulation.

[211] S. Blankenberg,et al. Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay. , 2019, Clinical chemistry.

[212] J. Karnon,et al. A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible ACS In the Emergency Department with High Sensitivity Troponin T (RAPID-TnT) Study. , 2019, Circulation.

[213] M. Akçakaya,et al. Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study. , 2019, Circulation. Cardiovascular imaging.

[214] Ò. Miró,et al. Clinical Use of a New High-Sensitivity Cardiac Troponin I Assay in Patients with Suspected Myocardial Infarction. , 2019, Clinical chemistry.

[215] J. Greenslade,et al. Two-Hour Algorithm for Rapid Triage of Suspected Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay. , 2019, Clinical chemistry.

[216] G. Hindricks,et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.

[217] W. Chan,et al. Association of periprocedural intravenous morphine use on clinical outcomes in ST‐elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta‐analysis , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[218] A. Goette,et al. Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. , 2019, European heart journal.

[219] A. Goette,et al. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial , 2019, The Lancet.

[220] B. Gorenek,et al. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[221] F. Apple,et al. Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians. , 2019, JAMA cardiology.

[222] Sergio Raposeiras-Roubín,et al. Papel de los bloqueadores beta en la enfermedad cardiovascular en 2019 , 2019, Revista Española de Cardiología.

[223] C. Held,et al. Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study. , 2019, International journal of cardiology.

[224] J. McMurray,et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. , 2019, The lancet. Diabetes & endocrinology.

[225] C. Fischbacher,et al. Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome , 2019, Journal of the American College of Cardiology.

[226] Samin K. Sharma,et al. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. , 2019, The New England journal of medicine.

[227] H. Jneid,et al. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction. , 2019, JACC. Cardiovascular interventions.

[228] Akshay S. Desai,et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.

[229] P. Sengupta,et al. Ticagrelor after pharmacological thrombolysis in patients with ST-segment elevation myocardial infarctions: insight from a trial sequential analysis , 2019, Journal of Thrombosis and Thrombolysis.

[230] M. Patterson,et al. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial. , 2019, JACC. Cardiovascular interventions.

[231] E. Omerovic,et al. Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study , 2019, Diabetes & vascular disease research.

[232] M. Postma,et al. A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. , 2019, The New England journal of medicine.

[233] N. Hagiwara,et al. Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. , 2019, The New England journal of medicine.

[234] C. Trankle,et al. Alirocumab in Acute Myocardial Infarction: Results from the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT). , 2019, Journal of cardiovascular pharmacology.

[235] Deepak L. Bhatt,et al. Ticagrelor in Patients with Stable Coronary Disease and Diabetes. , 2019, The New England journal of medicine.

[236] W. Rottbauer,et al. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. , 2019, The New England journal of medicine.

[237] R. Califf,et al. Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial. , 2019, JAMA cardiology.

[238] Á. Avezum,et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.

[239] G. Filippatos,et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.

[240] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[241] Maria Hagströmer,et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis , 2019, BMJ.

[242] Ò. Miró,et al. Predicting Major Adverse Events in Patients With Acute Myocardial Infarction. , 2019, Journal of the American College of Cardiology.

[243] Deepak L. Bhatt,et al. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. , 2019, JAMA cardiology.

[244] R. Bingisser,et al. Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction. , 2019, Journal of the American College of Cardiology.

[245] P. Jhund,et al. Healthcare disparities for women hospitalised with myocardial infarction and angina. , 2019, European heart journal. Quality of care & clinical outcomes.

[246] H. Katus,et al. RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction , 2019, European heart journal. Acute cardiovascular care.

[247] Qi Zhang,et al. Effects of Exercise-Based Cardiac Rehabilitation in Patients with Acute Coronary Syndrome: A Meta-Analysis , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[248] H. Thiele,et al. Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.

[249] Ò. Miró,et al. High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. , 2019, Clinical chemistry.

[250] Jeroen J. Bax,et al. Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials , 2019, Journal of the American College of Cardiology.

[251] A. Peters,et al. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. , 2019, The New England journal of medicine.

[252] Yong Hwan Park,et al. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial. , 2019, JAMA.

[253] H. Okayama,et al. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. , 2019, JAMA.

[254] L. Räber,et al. Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction. , 2019, European heart journal.

[255] W. Qiu,et al. Coronary artery lesion phenotype in frail older patients with non-ST-elevation acute coronary syndrome undergoing invasive care. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[256] M. Price,et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk , 2019, European heart journal.

[257] L. Räber,et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. , 2019, European heart journal.

[258] Emil Huriani,et al. Myocardial infarction patients' learning needs: Perceptions of patients, family members and nurses , 2019, International journal of nursing sciences.

[259] M. Vinciguerra,et al. The association of resistance training with mortality: A systematic review and meta-analysis , 2019, European journal of preventive cardiology.

[260] S. Blankenberg,et al. Evaluation of a new ultra-sensitivity troponin I assay in patients with suspected myocardial infarction. , 2019, International journal of cardiology.

[261] A. von Eckardstein,et al. Comparison of fourteen rule-out strategies for acute myocardial infarction. , 2019, International journal of cardiology.

[262] W. Shimizu,et al. Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction. , 2019, Circulation.

[263] M. Neuhäuser,et al. Early Clinical Outcomes of Surgical Myocardial Revascularization for Acute Coronary Syndromes Complicated by Cardiogenic Shock: A Report From the North‐Rhine‐Westphalia Surgical Myocardial Infarction Registry , 2019, Journal of the American Heart Association.

[264] Michael V Holmes,et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China , 2019, The Lancet.

[265] Jingang Yang,et al. Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction—an analysis from China Acute Myocardial Infarction (CAMI) registry , 2019, Journal of geriatric cardiology : JGC.

[266] A. Laupacis,et al. Temporal Trends of Women Enrollment in Major Cardiovascular Randomized Clinical Trials. , 2019, The Canadian journal of cardiology.

[267] H. Jneid,et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association , 2019, Circulation.

[268] P. Collinson,et al. High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers , 2019, Clinical chemistry and laboratory medicine.

[269] M. Woodward,et al. Cardiac Troponin T and Troponin I in the General Population , 2019, Circulation.

[270] A. Parkhomenko,et al. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation , 2019, The New England journal of medicine.

[271] C. Bullen,et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. , 2019, The Cochrane database of systematic reviews.

[272] B. Zinman,et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. , 2019, The New England journal of medicine.

[273] V. Cornelissen,et al. Feasibility, Acceptability, and Clinical Effectiveness of a Technology-Enabled Cardiac Rehabilitation Platform (Physical Activity Toward Health-I): Randomized Controlled Trial , 2019, Journal of medical Internet research.

[274] Martha M. Scheckel,et al. Improving Patient and Caregiver New Medication Education Using an Innovative Teach-back Toolkit , 2019, Journal of nursing care quality.

[275] Goran Krstačić,et al. ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicine , 2019, European journal of preventive cardiology.

[276] L. Piegas,et al. Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. , 2019, Journal of the American College of Cardiology.

[277] H. Crijns,et al. Coronary Angiography after Cardiac Arrest without ST‐Segment Elevation , 2019, The New England journal of medicine.

[278] S. Blankenberg,et al. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis , 2019, Circulation.

[279] G. Montalescot,et al. Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction? , 2019, American Journal of Cardiovascular Drugs.

[280] S. Blair,et al. Associations of Resistance Exercise with Cardiovascular Disease Morbidity and Mortality , 2019, Medicine and science in sports and exercise.

[281] M. Valdés,et al. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. , 2019, European journal of internal medicine.

[282] P. Serruys,et al. PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[283] J. Václavík,et al. Safety of early discharge in low risk patients after acute ST-segment elevation myocardial infarction, treated with primary percutaneous coronary intervention. Open label, randomized trial. , 2019, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[284] W. Qiu,et al. Cognitive Decline in Older Patients With Non‐ST Elevation Acute Coronary Syndrome , 2019, Journal of the American Heart Association.

[285] V. Fuster,et al. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials , 2019, European heart journal. Acute cardiovascular care.

[286] Diederick Grobbee,et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry , 2019, European journal of preventive cardiology.

[287] P. Kirchhof,et al. Digital learning and the future cardiologist , 2019, European heart journal.

[288] N. Mills,et al. Contemporary point of care cardiac troponin testing in suspected acute coronary syndrome , 2019, Heart.

[289] R. Body,et al. Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction. , 2019, International journal of cardiology.

[290] S. Seabury,et al. Medication adherence as a measure of the quality of care provided by physicians. , 2019, The American journal of managed care.

[291] Morten Wang Fagerland,et al. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study , 2019, American heart journal.

[292] John Fuller,et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials , 2019, The Lancet.

[293] Jun-Jie Zhang,et al. Intravascular ultrasound guidance reduces cardiac death and coronary revascularization in patients undergoing drug-eluting stent implantation: results from a meta-analysis of 9 randomized trials and 4724 patients , 2019, The International Journal of Cardiovascular Imaging.

[294] N. Hagiwara,et al. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study , 2019, Circulation.

[295] Deepak L. Bhatt,et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.

[296] Candace D. Speight,et al. Emergency Consent: Patients’ and Surrogates’ Perspectives on Consent for Clinical Trials in Acute Stroke and Myocardial Infarction , 2019, Journal of the American Heart Association.

[297] B. Lindahl,et al. A Rule‐Out Strategy Based on High‐Sensitivity Troponin and HEART Score Reduces Hospital Admissions , 2019, Annals of emergency medicine.

[298] Andreas Fors,et al. The impact of person-centred care on patients’ care experiences in relation to educational level after acute coronary syndrome: secondary outcome analysis of a randomised controlled trial , 2019, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[299] H. Thiele,et al. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial , 2019, Circulation.

[300] Deepak L. Bhatt,et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[301] W. Qiu,et al. One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study. , 2019, International journal of cardiology.

[302] Marc P. Bonaca,et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials , 2019, The Lancet.

[303] G. Filippatos,et al. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology , 2019, European journal of heart failure.

[304] M. Börjesson,et al. Increased Physical Activity Post–Myocardial Infarction Is Related to Reduced Mortality: Results From the SWEDEHEART Registry , 2018, Journal of the American Heart Association.

[305] B. Griffith,et al. Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease. , 2018, The Annals of thoracic surgery.

[306] Christopher J. Rush,et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.

[307] L. Räber,et al. Clinical Benefit of IVUS Guidance for Coronary Stenting: The ULTIMATE Step Toward Definitive Evidence? , 2018, Journal of the American College of Cardiology.

[308] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[309] D. Fischman,et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. , 2018, European heart journal.

[310] T. Friede,et al. Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction , 2018, European heart journal. Acute cardiovascular care.

[311] M. Chan,et al. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis , 2018, Journal of Cardiovascular Magnetic Resonance.

[312] J Wouter Jukema,et al. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome , 2018, The New England journal of medicine.

[313] Joanna M. Young,et al. Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction , 2018, JAMA cardiology.

[314] Mohammad Hossein Khosravi,et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[315] J. D. de Lemos,et al. Evaluation of a Novel Rule-Out Myocardial Infarction Protocol Incorporating High-Sensitivity Troponin T in a US Hospital. , 2018, Circulation.

[316] A. van Rossum,et al. Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial , 2018, European heart journal.

[317] D. Bhattacharya,et al. Barriers to medication adherence in patients prescribed medicines for the prevention of cardiovascular disease: a conceptual framework , 2018, The International journal of pharmacy practice.

[318] S. Cook,et al. Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial , 2018, British Medical Journal.

[319] P. Gao,et al. Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial. , 2018, Journal of the American College of Cardiology.

[320] W. O’Neill,et al. Cardiac Shock Care Centers: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[321] Sunil V. Rao,et al. Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[322] Ajay K. Jain,et al. Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes. , 2018, Journal of the American College of Cardiology.

[323] M. Pfeffer,et al. Editor’s Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction , 2018, European heart journal. Acute cardiovascular care.

[324] Fei Ye,et al. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial. , 2018, Journal of the American College of Cardiology.

[325] A. Maas,et al. European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection. , 2018, European heart journal.

[326] D. Atar,et al. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis , 2018, European heart journal. Cardiovascular pharmacotherapy.

[327] B. Guthrie,et al. Quality of Care in the United Kingdom after Removal of Financial Incentives , 2018, The New England journal of medicine.

[328] C. Fischbacher,et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial , 2018, The Lancet.

[329] C. Gibson,et al. The Teach Back Project: A System‐wide Evidence Based Practice Implementation , 2018, Journal of pediatric nursing.

[330] C. Berry,et al. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS. , 2018, Journal of the American College of Cardiology.

[331] Ò. Miró,et al. Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. , 2018, Clinical chemistry.

[332] C. Granger,et al. Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry. , 2018, JACC. Cardiovascular interventions.

[333] A. Jaffe,et al. Use of copeptin for rapid rule-out of acute myocardial infarction , 2018, European heart journal. Acute cardiovascular care.

[334] J. Messenger,et al. Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency: A Report From the National Cardiovascular Data Registry’s ACTION Registry , 2018, Circulation. Cardiovascular quality and outcomes.

[335] A. von Eckardstein,et al. Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction , 2018, European heart journal.

[336] Y. Hayashi,et al. Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention , 2018, PloS one.

[337] Nicholas Gant,et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial , 2018, Heart.

[338] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[339] Jeroen J. Bax,et al. Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[340] Susanna Price,et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. , 2018, European heart journal.

[341] H. Thiele,et al. One‐Year Outcomes after PCI Strategies in Cardiogenic Shock , 2018, The New England journal of medicine.

[342] Jeroen J. Bax,et al. Cardio-Oncology Services: rationale, organization, and implementation. , 2018, European heart journal.

[343] Ò. Miró,et al. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[344] L. Fauchier,et al. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[345] R. Arena,et al. Cardiac rehabilitation fitness changes and subsequent survival , 2018, European heart journal. Quality of care & clinical outcomes.

[346] G. Hillis,et al. Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials , 2018, Heart.

[347] Deepak L. Bhatt,et al. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials , 2018, Journal of Thrombosis and Thrombolysis.

[348] S. Schneider,et al. In-hospital major arrhythmias, arrhythmic death and resuscitation after successful primary percutaneous intervention for acute transmural infarction: a retrospective single-centre cohort study , 2018, BMC Cardiovascular Disorders.

[349] M. Stewart,et al. What are the effective elements in patient-centered and multimorbidity care? A scoping review , 2018, BMC Health Services Research.

[350] M. Hernán,et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[351] S. de Servi,et al. Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization , 2018, Circulation.

[352] Ò. Miró,et al. Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction. , 2018, Circulation.

[353] L. Morrison,et al. Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). , 2018, The Canadian journal of cardiology.

[354] G. Perkins,et al. Temporal Trends in Identification, Management, and Clinical Outcomes After Out-of-Hospital Cardiac Arrest: Insights From the Myocardial Ischaemia National Audit Project Database , 2018, Circulation. Cardiovascular interventions.

[355] M. Holzmann,et al. High-Sensitivity Troponins and Outcomes After Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[356] C. Bullen,et al. Nicotine replacement therapy versus control for smoking cessation. , 2018, The Cochrane database of systematic reviews.

[357] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management , 2018, European heart journal.

[358] J. Saw,et al. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. , 2018, Circulation.

[359] J. Greenslade,et al. Evaluating Rapid Rule-out of Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay at Presentation. , 2018, Clinical chemistry.

[360] Ò. Miró,et al. Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction. , 2018, Circulation.

[361] William J. Astle,et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies , 2018, The Lancet.

[362] R. Lenarczyk,et al. Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction. , 2018, The American journal of cardiology.

[363] Yong Hwan Park,et al. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial , 2018, The Lancet.

[364] James Woodcock,et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis , 2018, European Journal of Epidemiology.

[365] P. Dehghani,et al. Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital , 2018, Canadian Medical Association Journal.

[366] R. Schnabel,et al. Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome , 2018, Journal of the American Heart Association.

[367] V. Fuster,et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data , 2018, The Lancet.

[368] J. Smith,et al. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2018, Circulation. Cardiovascular interventions.

[369] G. Lip,et al. Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association , 2018, European heart journal. Acute cardiovascular care.

[370] Denise D. Quigley,et al. Patient Experience With Care and Its Association With Adherence to Hypertension Medications , 2018, American journal of hypertension.

[371] B. Whalley,et al. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis , 2018, European journal of preventive cardiology.

[372] A. Parkhomenko,et al. Editor’s Choice - Acute Cardiovascular Care Association Position Paper on Intensive Cardiovascular Care Units: An update on their definition, structure, organisation and function , 2018, European heart journal. Acute cardiovascular care.

[373] N. Mewton,et al. Effect and Safety of Morphine Use in Acute Anterior ST‐Segment Elevation Myocardial Infarction , 2018, Journal of the American Heart Association.

[374] G. Hindricks,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[375] T. Renné,et al. Discrimination of patients with type 2 myocardial infarction , 2017, European heart journal.

[376] E. Ohman,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials , 2017, European heart journal.

[377] H. Thiele,et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials , 2017, European heart journal.

[378] W. Aronow,et al. Temporal trends and outcomes of acute myocardial infarction in patients with cancer. , 2017, Annals of translational medicine.

[379] D. McManus,et al. Change in Cognitive Function in the Month After Hospitalization for Acute Coronary Syndromes: Findings From TRACE-CORE (Transition, Risks, and Actions in Coronary Events–Center for Outcomes Research and Education) , 2017, Circulation. Cardiovascular quality and outcomes.

[380] J. Greenslade,et al. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome , 2017, JAMA.

[381] D. Newby,et al. Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury , 2017, Circulation.

[382] T. Rea,et al. Impact of Regionalization of ST-Segment–Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services–Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission Lifeline Accelerator-2 , 2017, Circulation.

[383] E. Yeh,et al. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. , 2017, Journal of the American College of Cardiology.

[384] Deepak L. Bhatt,et al. International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies , 2017, Circulation.

[385] Khalid Yusoff,et al. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. , 2017, Lancet.

[386] Joan Mendivil,et al. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department , 2017, PloS one.

[387] A. von Eckardstein,et al. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction , 2017, Circulation.

[388] M. Nazzaro,et al. Instantaneous wave‐free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST‐segment elevation myocardial infarction: The WAVE study , 2017, American heart journal.

[389] S. Marzolini,et al. Effect of Cardiac Rehabilitation Dose on Mortality and Morbidity: A Systematic Review and Meta‐regression Analysis , 2017, Mayo Clinic proceedings.

[390] H. Thiele,et al. Optimized Prognosis Assessment in ST-Segment–Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score , 2017, Circulation. Cardiovascular imaging.

[391] Dorin Comaniciu,et al. Early diagnosis of acute coronary syndrome , 2017, European heart journal.

[392] P. Morange,et al. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study , 2017, European heart journal.

[393] H. Thiele,et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[394] M. Hadamitzky,et al. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial , 2017, The Lancet.

[395] S. Pocock,et al. Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. , 2017, Journal of the American College of Cardiology.

[396] D. Newby,et al. High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome , 2017, Circulation.

[397] G. Filippatos,et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.

[398] Ò. Miró,et al. Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction , 2017, Circulation.

[399] Ò. Miró,et al. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[400] Paul Dendale,et al. Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits , 2017, European journal of preventive cardiology.

[401] W. Rief,et al. Why current drug adherence programs fail: addressing psychological risk factors of nonadherence , 2017, Current opinion in psychiatry.

[402] L. Svensson,et al. Oxygen Therapy in Suspected Acute Myocardial Infarction , 2017, The New England journal of medicine.

[403] Deepak L. Bhatt,et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation , 2017, The New England journal of medicine.

[404] C. Held,et al. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction , 2017, The New England journal of medicine.

[405] Deepak L. Bhatt,et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[406] R. Twerenbold,et al. Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[407] E. Vicaut,et al. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials , 2017, The Lancet.

[408] Z. Motovska,et al. Characteristics and Survival Determinants in Patients After Out-of-Hospital Cardiac Arrest in The Era of 24/7 Coronary Intervention Facilities. , 2017, Heart, lung & circulation.

[409] J. Greenslade,et al. Direct Comparison of 2 Rule-Out Strategies for Acute Myocardial Infarction: 2-h Accelerated Diagnostic Protocol vs 2-h Algorithm. , 2017, Clinical chemistry.

[410] J. Tuomilehto,et al. The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV , 2017, Diabetes Care.

[411] K. Mahaffey,et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.

[412] R. West,et al. β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction , 2017, Journal of the American College of Cardiology.

[413] I. Frederix,et al. Who needs secondary prevention? , 2017, European journal of preventive cardiology.

[414] V. Fuster,et al. Role of the polypill for secondary prevention in ischaemic heart disease , 2017, European journal of preventive cardiology.

[415] J. Keenan. Improving adherence to medication for secondary cardiovascular disease prevention , 2017, European journal of preventive cardiology.

[416] J. Carroll,et al. Acute Mitral Regurgitation Secondary to Papillary Muscle Tear: Is Transcatheter Edge-to-Edge Mitral Valve Repair a New Paradigm? , 2017, Circulation. Cardiovascular interventions.

[417] B. McNally,et al. Direct Transport to a Percutaneous Cardiac Intervention Center and Outcomes in Patients With Out-of-Hospital Cardiac Arrest , 2017, Circulation. Cardiovascular quality and outcomes.

[418] M. Vidovich,et al. ST‐elevation acute myocardial infarction in pregnancy: 2016 update , 2017, Clinical cardiology.

[419] A. Kastrati,et al. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients , 2017, Circulation. Cardiovascular interventions.

[420] S. Bangalore,et al. Preventive Strategies for Contrast-Induced Acute Kidney Injury: And the Winner Is…. , 2017, Circulation. Cardiovascular interventions.

[421] Ò. Miró,et al. Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I , 2017, Circulation.

[422] Lale Tokgözoğlu,et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel , 2017, European heart journal.

[423] D. Newby,et al. Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction , 2017, Circulation.

[424] V. Fuster,et al. Neutrophil stunning by metoprolol reduces infarct size , 2017, Nature Communications.

[425] Joanna M. Young,et al. Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. , 2017, Annals of internal medicine.

[426] Deepak L. Bhatt,et al. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients , 2017, European heart journal.

[427] P. Jüni,et al. Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation , 2017, European heart journal.

[428] Stefan Blankenberg,et al. High-sensitivity assays for troponin in patients with cardiac disease , 2017, Nature Reviews Cardiology.

[429] C. Held,et al. Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes , 2017, American heart journal.

[430] A. Jaffe,et al. Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin , 2017, European heart journal. Acute cardiovascular care.

[431] A. Jaffe,et al. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies , 2017, European heart journal. Acute cardiovascular care.

[432] J. Wildberger,et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial , 2017, The Lancet.

[433] J. Deckers,et al. Lessons from contemporary trials of cardiovascular prevention and rehabilitation: A systematic review and meta-analysis. , 2017, International journal of cardiology.

[434] F. Neumann,et al. Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.

[435] A. Keech,et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease , 2017, The New England journal of medicine.

[436] I. Elgendy,et al. Meta-Analysis of Randomized Trials of Long-Term All-Cause Mortality in Patients With Non-ST-Elevation Acute Coronary Syndrome Managed With Routine Invasive Versus Selective Invasive Strategies. , 2017, The American journal of cardiology.

[437] H. McGee,et al. Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry. , 2017, International journal of cardiology.

[438] D. Yellon,et al. A new era in the management of type 2 diabetes: Is cardioprotection at long last a reality? , 2017, International journal of cardiology.

[439] P. Reynier,et al. Intravenous beta-blockers in ST-segment elevation myocardial infarction: A systematic review and meta-analysis. , 2017, International journal of cardiology.

[440] Ò. Miró,et al. Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin , 2017, Clinical Research in Cardiology.

[441] Zachary F. Meisel,et al. Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial , 2016, British Medical Journal.

[442] I. Elgendy,et al. Intravenous β-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. , 2016, International journal of cardiology.

[443] G. Guyatt,et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. , 2016, JAMA.

[444] K. Huber,et al. Copeptin for the early rule-out of non-ST-elevation myocardial infarction. , 2016, International Journal of Cardiology.

[445] G. Lip,et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. , 2016, The New England journal of medicine.

[446] C. Held,et al. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial , 2016, European heart journal.

[447] K. Rentsch,et al. Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. , 2016, American heart journal.

[448] Ò. Miró,et al. Clinical Effect of Sex-Specific Cutoff Values of High-Sensitivity Cardiac Troponin T in Suspected Myocardial Infarction. , 2016, JAMA cardiology.

[449] J. Cigarroa,et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, The Journal of thoracic and cardiovascular surgery.

[450] R. McNamara,et al. Left ventricular thrombi after STEMI in the primary PCI era: A systematic review and meta-analysis. , 2016, International journal of cardiology.

[451] F. Marvel,et al. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. , 2016, European heart journal. Quality of care & clinical outcomes.

[452] B. Pathik,et al. Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. , 2016, European heart journal cardiovascular Imaging.

[453] Olivier Morel,et al. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non–ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting) , 2016, Circulation.

[454] J. Ferrières,et al. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study , 2016, British Medical Journal.

[455] K. Bønaa,et al. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. , 2016, The New England journal of medicine.

[456] W. Qiu,et al. Engaging older patients in cardiovascular research: observational analysis of the ICON-1 study , 2016, Open Heart.

[457] S. Goland,et al. High-Risk Cardiac Disease in Pregnancy: Part I. , 2016, Journal of the American College of Cardiology.

[458] J. Greenslade,et al. Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. , 2016, JAMA cardiology.

[459] R. Body,et al. Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. , 2016, Annals of emergency medicine.

[460] K. Rentsch,et al. Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction , 2016, European heart journal.

[461] I. Komuro,et al. Clinical Impact of Ventricular Tachycardia and/or Fibrillation During the Acute Phase of Acute Myocardial Infarction on In-Hospital and 5-Year Mortality Rates in the Percutaneous Coronary Intervention Era. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[462] V. Fuster,et al. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention. , 2016, Journal of the American College of Cardiology.

[463] J. Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[464] C. Terkelsen,et al. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial , 2016, The Lancet.

[465] I. Scott,et al. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. , 2016, The Cochrane database of systematic reviews.

[466] V. Fuster,et al. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function. , 2016, Journal of the American College of Cardiology.

[467] C. Held,et al. Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. , 2016, Journal of the American College of Cardiology.

[468] N. Codella,et al. Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR. , 2016, JACC. Cardiovascular imaging.

[469] D. Atar,et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[470] Matthias Gutberlet,et al. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.

[471] R. Body,et al. Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study. , 2016, International journal of cardiology.

[472] C. Granger,et al. Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. , 2016, Journal of the American College of Cardiology.

[473] H. Dalal,et al. Telehealth technologies could improve suboptimal rates of participation in cardiac rehabilitation , 2016, Heart.

[474] Marc P. Bonaca,et al. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. , 2016, European heart journal.

[475] I. Ekman,et al. Person-centred care improves self-efficacy to control symptoms after acute coronary syndrome: a randomized controlled trial , 2016, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[476] S. Windecker,et al. Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. , 2016, American heart journal.

[477] S. Mathew,et al. Medication Adherence: Truth and Consequences☆ , 2016, The American journal of the medical sciences.

[478] A. Schoenenberger,et al. Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset , 2016, European heart journal. Acute cardiovascular care.

[479] Ò. Miró,et al. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infarction. , 2016, International journal of cardiology.

[480] B. Bendz,et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial , 2016, The Lancet.

[481] P. Croisille,et al. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment–Elevation Myocardial Infarction: The MIMI Study , 2016, Circulation. Cardiovascular interventions.

[482] J. Greenslade,et al. Two-Hour Algorithm for Triage toward Rule-Out and Rule-In of Acute Myocardial Infarction by Use of High-Sensitivity Cardiac Troponin I. , 2016, Clinical chemistry.

[483] Y. Cha,et al. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention. , 2016, The American journal of cardiology.

[484] C. Held,et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome , 2016, Heart.

[485] K. Filion,et al. Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials , 2016, Journal of the American Heart Association.

[486] G. Kumar,et al. Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10-year period , 2016, Journal of Cancer Research and Clinical Oncology.

[487] F. Fedele,et al. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. , 2016, Journal of the American College of Cardiology.

[488] P. Serruys,et al. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial , 2016, The Lancet.

[489] P. Dehghani,et al. Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome , 2016, Circulation.

[490] H. Nathoe,et al. Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. , 2016, Journal of the American College of Cardiology.

[491] B. Franklin,et al. Cardiac Rehabilitation and Healthy Life-Style Interventions: Rectifying Program Deficiencies to Improve Patient Outcomes. , 2016, Journal of the American College of Cardiology.

[492] P. Norman,et al. Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003–2013 , 2016, Heart.

[493] R. Clark,et al. The effectiveness of the teach‐back method on adherence and self‐management in health education for people with chronic disease: a systematic review , 2016, JBI database of systematic reviews and implementation reports.

[494] G. Filippatos,et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology , 2016, European journal of heart failure.

[495] P. Collinson,et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study , 2015, The Lancet.

[496] Leif E. Peterson,et al. Optimizing Evaluation of Patients with Low-to-Intermediate-Risk Acute Chest Pain: A Randomized Study Comparing Stress Myocardial Perfusion Tomography Incorporating Stress-Only Imaging Versus Cardiac CT , 2015, The Journal of Nuclear Medicine.

[497] L. Køber,et al. Long-Term Clinical Impact of Coronary CT Angiography in Patients With Recent Acute-Onset Chest Pain: The Randomized Controlled CATCH Trial. , 2015, JACC. Cardiovascular imaging.

[498] Ò. Miró,et al. Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin. , 2015, Clinical chemistry.

[499] J. Hallas,et al. Improving Medication Adherence in Patients with Hypertension: A Randomized Trial. , 2015, The American journal of medicine.

[500] B. Zinman,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[501] Yangsoo Jang,et al. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. , 2015, JAMA.

[502] M. Marszałł,et al. Abstract 19153: Morphine Delays and Attenuates Ticagrelor Exposure and Action in Patients With Myocardial Infarction: The Randomized, Double-blind, Placebo-controlled Impression Trial , 2015 .

[503] N. Al-Attar,et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.

[504] K. Dickstein,et al. Safety and health status following early discharge in patients with acute myocardial infarction treated with primary PCI: a randomized trial , 2015, European journal of preventive cardiology.

[505] Y. Rosenberg,et al. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction. , 2015, Journal of the American College of Cardiology.

[506] H. Gluyas,et al. Patient-centred care: improving healthcare outcomes. , 2015, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[507] S. Pocock,et al. Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. , 2015, Journal of the American College of Cardiology.

[508] Mohd Abdul Nafay Shoeb. Brain targeted drug delivery system: An overview of recent developments and challenges , 2015 .

[509] C. V. van Mieghem,et al. Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[510] L. Køber,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[511] Wei Liu,et al. Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: A systematic review and meta-analysis , 2015, European journal of preventive cardiology.

[512] A. Camm,et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[513] Neal W. Dickert,et al. Involving patients in enrolment decisions for acute myocardial infarction trials , 2015, BMJ : British Medical Journal.

[514] M. Price,et al. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. , 2015, European heart journal.

[515] F. Fernández‐Avilés,et al. Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis , 2015, Heart.

[516] Neal W. Dickert,et al. Cardiac Arrest: A Treatment Algorithm for Emergent Invasive Cardiac Procedures in the Resuscitated Comatose Patient. , 2015, Journal of the American College of Cardiology.

[517] C. Vilaplana,et al. Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction. , 2015, International journal of cardiology.

[518] E. Piccaluga,et al. Management and Long-Term Prognosis of Spontaneous Coronary Artery Dissection. , 2015, The American journal of cardiology.

[519] Sergio Raposeiras-Roubín,et al. En la era actual existe beneficio pronóstico del tratamiento con bloqueadores beta tras un síndrome coronario agudo con función sistólica conservada , 2015 .

[520] K. Rentsch,et al. Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction. , 2015, International journal of cardiology.

[521] L. Tokgozoglu,et al. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2015, Journal of the American Heart Association.

[522] M. Valgimigli,et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial , 2015, The Lancet.

[523] Peter Cameron,et al. Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction , 2015, Circulation.

[524] Mao Chen,et al. Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention. , 2015, The American journal of cardiology.

[525] R. Geocadin,et al. Neurological prognostication after cardiac arrest , 2015, Current opinion in critical care.

[526] G. Montalescot,et al. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction , 2015, Thrombosis and Haemostasis.

[527] Marc P. Bonaca,et al. Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[528] H. Schunkert,et al. Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial. , 2015, Journal of the American College of Cardiology.

[529] F. Van de Werf,et al. Evolving therapies for myocardial ischemia/reperfusion injury. , 2015, Journal of the American College of Cardiology.

[530] Sunil V. Rao,et al. The conundrum of reducing ischemic and bleeding events after PCI. , 2015, Journal of the American College of Cardiology.

[531] Barry J. Davis,et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials , 2015, The Lancet.

[532] Sunil V. Rao,et al. Randomized trial of primary PCI with or without routine manual thrombectomy. , 2015, The New England journal of medicine.

[533] G. Stone,et al. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. , 2015, JAMA.

[534] I. Buchan,et al. Access and Non–Access Site Bleeding After Percutaneous Coronary Intervention and Risk of Subsequent Mortality and Major Adverse Cardiovascular Events: Systematic Review and Meta-Analysis , 2015, Circulation. Cardiovascular interventions.

[535] J. Haerting,et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. , 2015, The Cochrane database of systematic reviews.

[536] H. Swanton,et al. Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.

[537] R. Dreyer,et al. Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries , 2015, Circulation.

[538] C. Kwok,et al. Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. , 2015, JACC. Cardiovascular interventions.

[539] J. Zamorano,et al. The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. , 2015, European heart journal cardiovascular Imaging.

[540] W. Qiu,et al. Outcomes following primary percutaneous coronary intervention in the setting of cardiac arrest: A registry database study , 2015, European heart journal. Acute cardiovascular care.

[541] Rosy Tirimacco,et al. Alternative models of cardiac rehabilitation: A systematic review , 2015, European journal of preventive cardiology.

[542] Paul Dendale,et al. A review of telerehabilitation for cardiac patients , 2015, Journal of telemedicine and telecare.

[543] K. Malmberg,et al. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: Long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort , 2015, Diabetes & vascular disease research.

[544] I. Xanthopoulou,et al. Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2014, Circulation. Cardiovascular interventions.

[545] Braunwald,et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.

[546] J. Gunn,et al. Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society). , 2014, JACC. Cardiovascular interventions.

[547] P. Kirchhof,et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association , 2014, European heart journal.

[548] D. Holmes,et al. Spontaneous Coronary Artery Dissection: Revascularization Versus Conservative Therapy , 2014, Circulation. Cardiovascular interventions.

[549] B. Prendergast,et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[550] Jonathan H Seltzer,et al. Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. , 2014, JAMA internal medicine.

[551] J. Saw,et al. Spontaneous Coronary Artery Dissection: Association With Predisposing Arteriopathies and Precipitating Stressors and Cardiovascular Outcomes , 2014, Circulation. Cardiovascular interventions.

[552] K. Alexander,et al. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. , 2014, The American journal of medicine.

[553] P. Armstrong,et al. ST–Segment-Elevation Myocardial Infarction Patients Randomized to a Pharmaco-Invasive Strategy or Primary Percutaneous Coronary Intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-Year Mortality Follow-Up , 2014, Circulation.

[554] Holger Thiele,et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[555] E. Omerovic,et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. , 2014, The New England journal of medicine.

[556] G. Schuler,et al. Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial. , 2014, Journal of the American College of Cardiology.

[557] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[558] E. Vicaut,et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. , 2014, The New England journal of medicine.

[559] M. Flather,et al. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study. , 2014, European heart journal.

[560] A. Briggs,et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial , 2014, European heart journal.

[561] Daniel C. Lee,et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. , 2014, JACC. Cardiovascular imaging.

[562] V. Fuster,et al. A polypill strategy to improve adherence: results from the FOCUS project. , 2014, Journal of the American College of Cardiology.

[563] L. Rydén,et al. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial. , 2014, The lancet. Diabetes & endocrinology.

[564] H. White,et al. Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. , 2014, American heart journal.

[565] A. Go,et al. β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. , 2014, Journal of the American College of Cardiology.

[566] J. Beyer-Westendorf,et al. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. , 2014, European heart journal.

[567] Hynek Pikhart,et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data , 2014, BMJ : British Medical Journal.

[568] S. Marzolini,et al. Sex differences in cardiac rehabilitation enrollment: a meta-analysis. , 2014, The Canadian journal of cardiology.

[569] M. Chung,et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. , 2014, Circulation.

[570] G. Schuler,et al. Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine , 2014, Trials.

[571] C. Berry,et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI) , 2014, Journal of the American College of Cardiology.

[572] Somjot S. Brar,et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.

[573] H. Suryapranata,et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. , 2014, The American journal of cardiology.

[574] S. Blankenberg,et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study , 2014, European heart journal.

[575] U. Elkayam,et al. Pregnancy-Associated Acute Myocardial Infarction: A Review of Contemporary Experience in 150 Cases Between 2006 and 2011 , 2014, Circulation.

[576] V. Fuster,et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). , 2014, Journal of the American College of Cardiology.

[577] G. Stone,et al. The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial , 2014, European heart journal. Acute cardiovascular care.

[578] C. Mueller. Biomarkers and acute coronary syndromes: an update. , 2014, European heart journal.

[579] R. Twerenbold,et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. , 2014, European heart journal.

[580] G. Castelnuovo,et al. Assessing Depression in Cardiac Patients: What Measures Should Be Considered? , 2014, Depression research and treatment.

[581] R. D. de Winter,et al. Standardizing definitions for hybrid coronary revascularization. , 2014, The Journal of thoracic and cardiovascular surgery.

[582] Pierre Coste,et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score , 2014, BMJ Open.

[583] J. Tamayo-Sarver,et al. Effect of Prehospital Cardiac Catheterization Lab Activation on Door-to-Balloon Time, Mortality, and False-Positive Activation , 2014, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[584] J. Jukema,et al. Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. , 2013, The American journal of cardiology.

[585] Deepak L. Bhatt,et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data , 2013, The Lancet.

[586] M. Wise,et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[587] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.

[588] G. Schuler,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[589] B. Drew,et al. Arrhythmias in patients with acute coronary syndrome in the first 24 hours of hospitalization. , 2013, Heart & lung : the journal of critical care.

[590] E. Vicaut,et al. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). , 2013, The American journal of cardiology.

[591] David Erlinge,et al. Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[592] H. Jneid,et al. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. , 2013, International journal of cardiology.

[593] V. Fuster,et al. Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. , 2013, International journal of cardiology.

[594] K. Huber,et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention , 2013, European heart journal.

[595] C. Berry,et al. Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.

[596] T. Chua,et al. Stress myocardial perfusion imaging for the evaluation and triage of chest pain in the emergency department: A randomized controlled trial , 2013, Journal of Nuclear Cardiology.

[597] E. Vicaut,et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. , 2013, The New England journal of medicine.

[598] R. Califf,et al. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. , 2013, International journal of cardiology.

[599] A. Íñiguez,et al. Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.

[600] Motohiro Kosugi,et al. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2013, Cardiovascular revascularization medicine : including molecular interventions.

[601] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[602] Deepak L. Bhatt,et al. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial , 2013, The Lancet.

[603] K. Rentsch,et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. , 2013, European heart journal.

[604] A. Kastrati,et al. Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention , 2013, Circulation. Cardiovascular interventions.

[605] C. Granger,et al. Emergency Department Bypass for ST-Segment–Elevation Myocardial Infarction Patients Identified With a Prehospital Electrocardiogram: A Report From the American Heart Association Mission Lifeline Program , 2013, Circulation.

[606] R. Diaz,et al. Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes. , 2013, JACC. Heart failure.

[607] R. Perera,et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. , 2013, The Cochrane database of systematic reviews.

[608] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[609] Gregg W Stone,et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. , 2013, The New England journal of medicine.

[610] Tom Adriaenssens,et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[611] S. Iliffe,et al. Frailty in elderly people , 2013, The Lancet.

[612] R. Twerenbold,et al. Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. , 2013, American heart journal.

[613] T. Villines,et al. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials. , 2013, Journal of the American College of Cardiology.

[614] G. Stone,et al. Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes , 2013, Annals of Internal Medicine.

[615] E. Ruokonen,et al. Therapeutic hypothermia after out-of-hospital cardiac arrest in Finnish intensive care units: the FINNRESUSCI study , 2013, Intensive Care Medicine.

[616] S. Glickman,et al. The Impact of a Statewide Pre-Hospital STEMI Strategy to Bypass Hospitals Without Percutaneous Coronary Intervention Capability on Treatment Times , 2013, Circulation.

[617] J. Lock,et al. Transcatheter Closure of Post-myocardial Infarction Ventricular Septal Rupture , 2013, Circulation. Cardiovascular interventions.

[618] C. Brulin,et al. Longer pre-hospital delay in first myocardial infarction among patients with diabetes: an analysis of 4266 patients in the Northern Sweden MONICA Study , 2013, BMC Cardiovascular Disorders.

[619] J. Wetterslev,et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. , 2013, JAMA internal medicine.

[620] S. Kurz,et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.

[621] A. van Rossum,et al. Long-term follow-up of the viability guided angioplasty after acute myocardial infarction (VIAMI) trial. , 2012, International journal of cardiology.

[622] N. Parakh. Intraaortic balloon support for myocardial infarction with cardiogenic shock , 2012 .

[623] S. Pedersen,et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[624] P. Serruys,et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.

[625] Circulation Editors' Picks: Most Read Articles in Cardiovascular Interventions , 2012 .

[626] Deepak L. Bhatt,et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. , 2012, JAMA.

[627] Deepak L. Bhatt,et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. , 2012, New England Journal of Medicine.

[628] Geoffrey C. Williams,et al. Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. , 2012, The American journal of cardiology.

[629] J. Gräsner,et al. Choice of hospital after out-of-hospital cardiac arrest - a decision with far-reaching consequences: a study in a large German city , 2012, Critical Care.

[630] C. Schindler,et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. , 2012, Archives of internal medicine.

[631] C. Guerriero,et al. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop , 2012, The European Journal of Health Economics.

[632] C. Cannon,et al. Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes: A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial , 2012 .

[633] J. Alpert,et al. How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .

[634] L. Räber,et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.

[635] J. Alpert,et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. , 2012, European heart journal.

[636] D. Flynn,et al. Engaging patients in health care decisions in the emergency department through shared decision-making: a systematic review. , 2012, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[637] J. Fleg,et al. Coronary CT angiography versus standard evaluation in acute chest pain. , 2012, The New England journal of medicine.

[638] M. Niemelä,et al. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention. , 2012, The American journal of cardiology.

[639] P. Stella,et al. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-mont , 2012, Journal of the American College of Cardiology.

[640] Giuseppe Biondi-Zoccai,et al. TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. , 2012, Contemporary clinical trials.

[641] K. Dickstein,et al. Adherence of heart failure patients to exercise: barriers and possible solutions , 2012, European journal of heart failure.

[642] Scott R Beach,et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. , 2012, The American journal of cardiology.

[643] Á. Lanas,et al. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy , 2012, Heart.

[644] C. Gatsonis,et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. , 2012, The New England journal of medicine.

[645] J. Piccini,et al. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). , 2012, The American journal of cardiology.

[646] J. Deckers,et al. Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes. , 2012, The American journal of cardiology.

[647] Manesh R. Patel,et al. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department , 2012, Journal of Nuclear Cardiology.

[648] E. Vicaut,et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[649] C. Cannon,et al. Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor: Insights From the Platelet Inhibition and Patient Outcomes Trial , 2012, Circulation.

[650] J. Bronzwaer,et al. Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial) , 2012, Trials.

[651] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[652] A. Kastrati,et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. , 2011, The New England journal of medicine.

[653] M. Reidenberg. Drug Discontinuation Effects Are Part of the Pharmacology of a Drug , 2011, Journal of Pharmacology and Experimental Therapeutics.

[654] U. Siebert,et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. , 2011, JACC. Cardiovascular interventions.

[655] H. Khalil. Psychological and pharmacological interventions for depression in patients with coronary artery disease , 2011 .

[656] Sunil V. Rao,et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). , 2011, The American journal of cardiology.

[657] Kenneth W Lin,et al. Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[658] E. Vicaut,et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.

[659] G. Schuler,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[660] R. Twerenbold,et al. Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction , 2011, Circulation.

[661] S. Ebrahim,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2011, The Cochrane database of systematic reviews.

[662] H. Krumholz,et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. , 2011, JAMA.

[663] C. Cannon,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial , 2011, BMJ : British Medical Journal.

[664] J. Gea,et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. , 2011, European heart journal.

[665] A. Yan,et al. Factors influencing underutilization of evidence-based therapies in women. , 2011, European heart journal.

[666] X. Jouven,et al. Atrial Fibrillation and Death After Myocardial Infarction: A Community Study , 2011, Circulation.

[667] Sunil V. Rao,et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[668] M. Mamas,et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. , 2011, European heart journal.

[669] M. Zembala,et al. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). , 2011, The American journal of cardiology.

[670] W. Wongcharoen,et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. , 2011, European heart journal.

[671] L. Badano,et al. Usefulness of contrast stress-echocardiography or exercise-electrocardiography to predict long-term acute coronary syndromes in patients presenting with chest pain without electrocardiographic abnormalities or 12-hour troponin elevation. , 2011, The American journal of cardiology.

[672] William Wijns,et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. , 2010, JACC. Cardiovascular interventions.

[673] Deepak L. Bhatt,et al. Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.

[674] A. Stevens,et al. Making the Most of Your Healthcare intervention for older adults with multiple chronic illnesses. , 2010, Patient education and counseling.

[675] G. Schuler,et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. , 2010, European heart journal.

[676] J. R. Carmona,et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies , 2010, European heart journal.

[677] S. Yusuf,et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.

[678] Sunil V. Rao,et al. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. , 2010, JAMA.

[679] P. Armstrong,et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. , 2010, European heart journal.

[680] C. Terkelsen,et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. , 2010, JAMA.

[681] Z. Siudak,et al. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). , 2010, The American journal of cardiology.

[682] Armando Pérez de Prado,et al. Role of the Paclitaxel-Eluting Stent and Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Postfibrinolysis Angioplasty: The GRACIA-3 Randomized Clinical Trial , 2010, Circulation. Cardiovascular interventions.

[683] L. Wallentin,et al. Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[684] M. Beahrs,et al. Very Rapid Treatment of ST-Segment–Elevation Myocardial Infarction: Utilizing Prehospital Electrocardiograms to Bypass the Emergency Department , 2010, Circulation. Cardiovascular quality and outcomes.

[685] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[686] S. Pocock,et al. A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[687] S. Pocock,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[688] Sunil V. Rao,et al. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. , 2010, Journal of the American College of Cardiology.

[689] X. Jouven,et al. Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest: Insights From the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry , 2010, Circulation. Cardiovascular interventions.

[690] S. Blankenberg,et al. Copeptin improves early diagnosis of acute myocardial infarction. , 2010, Journal of the American College of Cardiology.

[691] C. Callaway,et al. Receiving hospital characteristics associated with survival after out-of-hospital cardiac arrest. , 2010, Resuscitation.

[692] T. Ikeda,et al. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[693] C. Lau,et al. Clinical and angiographic findings of complete atrioventricular block in acute inferior myocardial infarction. , 2010, Annals of the Academy of Medicine, Singapore.

[694] S. Yusuf,et al. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[695] W Skalli,et al. EOS orthopaedic imaging system to study patellofemoral kinematics: assessment of uncertainty. , 2010, Orthopaedics & traumatology, surgery & research : OTSR.

[696] S. Halvorsen,et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.

[697] Gregg W Stone,et al. Platelet inhibition with cangrelor in patients undergoing PCI. , 2009, The New England journal of medicine.

[698] Deepak L. Bhatt,et al. Intravenous platelet blockade with cangrelor during PCI. , 2009, The New England journal of medicine.

[699] C. Terkelsen,et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. , 2009, The American journal of cardiology.

[700] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.

[701] Stefan Blankenberg,et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[702] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[703] S. Yusuf,et al. Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[704] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[705] Alfonso Castro-Beiras,et al. Seguridad y viabilidad del retorno precoz de pacientes transferidos para angioplastia primaria a sus centros de origen , 2009 .

[706] K. Eagle,et al. Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores , 2009, PloS one.

[707] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.

[708] R. Califf,et al. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction* , 2009, Critical care medicine.

[709] E. Antman,et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.

[710] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[711] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[712] G. Finet,et al. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). , 2009, The American journal of cardiology.

[713] P. Touboul,et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. , 2009, European heart journal.

[714] N. Morgenthaler,et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[715] T. Huynh,et al. Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment–Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies , 2009, Circulation.

[716] H. Bøtker,et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. , 2009, European heart journal.

[717] J. Ware,et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.

[718] P. Armstrong,et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. , 2009, JAMA.

[719] S. Hohnloser,et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. , 2009, European heart journal.

[720] B. McNally,et al. Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regions. , 2009, JACC. Cardiovascular interventions.

[721] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[722] E. Bordeleau,et al. Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction , 2009, The International Journal of Cardiovascular Imaging.

[723] M. Hadamitzky,et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel , 2009, Thrombosis and Haemostasis.

[724] J. Fajadet,et al. "Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[725] A. Kastrati,et al. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. , 2009, JAMA.

[726] J. Gore,et al. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). , 2009, The American journal of cardiology.

[727] S. Solomon,et al. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). , 2008, The American journal of cardiology.

[728] G. Lamas,et al. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. , 2008, European heart journal.

[729] K. Schindler,et al. Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. , 2008, European heart journal.

[730] A. Shah,et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. , 2008, JAMA.

[731] M. Sabatine,et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[732] R. Byrne,et al. Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. , 2008, European heart journal.

[733] Sunil V. Rao,et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[734] Samuel O. M. Manda,et al. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database , 2008, Heart.

[735] K. Winters,et al. Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel , 2008, Journal of clinical pharmacology.

[736] G. Lip,et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.

[737] A. Kastrati,et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.

[738] M. Flather,et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial , 2008, The Lancet.

[739] S. Fujiwara,et al. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction. , 2008, The American journal of cardiology.

[740] D. Jacobs,et al. Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality. , 2008, The American journal of cardiology.

[741] S. Yusuf,et al. The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. , 2008, European heart journal.

[742] Dominique Mottier,et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. , 2008, Journal of the American College of Cardiology.

[743] J. Trickett,et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. , 2008, The New England journal of medicine.

[744] J. Ioannidis,et al. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. , 2007, American heart journal.

[745] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[746] P. Aegerter,et al. Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation. , 2007, Resuscitation.

[747] Timothy D. Henry,et al. A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction , 2007, Circulation.

[748] B. Gersh,et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2007, European heart journal.

[749] A. Budaj,et al. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes. , 2007, American heart journal.

[750] H. V. van Hout,et al. Depression and the risk for cardiovascular diseases: systematic review and meta analysis , 2007, International journal of geriatric psychiatry.

[751] D. Moser,et al. "The rust of life": impact of anxiety on cardiac patients. , 2007, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[752] C. Lau,et al. ORIGINAL RESEARCHCRITICAL CARE MEDICINETransient Atrial Fibrillation Complicating Acute Inferior Myocardial Infarction: Implications for Future Risk of Ischemic Stroke , 2007 .

[753] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[754] A. Parkhomenko,et al. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis. , 2007, European heart journal.

[755] C. Weston,et al. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome , 2007, Heart.

[756] E. Antman,et al. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. , 2007, European heart journal.

[757] F. Fernández‐Avilés,et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. , 2007, European heart journal.

[758] P. Lesault,et al. Six-Month Outcome of Emergency Percutaneous Coronary Intervention in Resuscitated Patients After Cardiac Arrest Complicating ST-Elevation Myocardial Infarction , 2007, Circulation.

[759] M. Noc,et al. Acute ST-elevation myocardial infarction after successful cardiopulmonary resuscitation. , 2007, Resuscitation.

[760] J. Tu,et al. Clinical ResearchInterventional CardiologyRescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis of Randomized Trials , 2007 .

[761] W. Laskey,et al. Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[762] G. Lamas,et al. Coronary intervention for persistent occlusion after myocardial infarction. , 2006, The New England journal of medicine.

[763] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.